Welcome to “Talking Psychedelics”, where Frshminds takes you on a deep dive with the driving forces shaping the psychedelics industry. Today we touch base with Jesse Hanson, PhD of Dimensions Retreats. Jesse explains the holistic approach of Dimension Retreats, how he and his colleagues spent close to a year researching ancient plant medicine traditions and the surprises that came out of that process.

Jeff Kolesnikowicz wasn’t new to psychedelics last summer. But instead of undergoing the treatment at a clinic, he was at a retreat in Ontario cottage country.

In this episode, Joe interviews Christopher Dawson and Andrew Galloway: Co-Founders and CEO and COO, respectively, of Dimensions; a Canadian-based company creating retreats that blend traditional plant ceremonies with neuroscience and a luxurious, five-star environment

The Canadian company, Dimensions, launches its first retirement destination. ‘Dimensions Algonquin Highlands’ will offer treatments based on medicinal plants.

DesignAgency has released plans for a “psychedelic healing retreat” in Ontario called Dimensions Algonquin Highlands.

Dimensions, a Canadian company offering safe and legal psychedelic-assisted experiences, has revealed designs for “Dimensions Algonquin Highlands,” its first Retreat destination.

A brand new retreat is underway in Ontario, and it comes with lake views, stargazing cabins, and… psychedelics.

Pulled in so many directions by our modern lifestyle, it’s easy to lose sight of how vital self-care can be.

Recent research suggests that cannabis-assisted psychotherapy can lead to mental health breakthroughs.

Two psychedelic industry insiders reflect on the progress and flaws within Health Canada’s recent amendment to the Special Access Program.

“The cannabis boom continues to rage rampantly, while another major industry, previously inaccessible because of the War on Drugs and research restrictions, is making its way to the forefront.”

Truffle Report Editor James Stephen sits down with the team from Dimensions to talk about the challenges and opportunities of building a legal psychedelic retreat in Ontario, Canada.

As a result, the Canadian Psychedlic Association responds with a Memorandum of Regulatory Approval, which advises medicinal psilocybin therapy to be authorized in a safe and theraputic environment.

Most of our time this week was spent covering a sweeping, long-shot bid to legalize cannabis from Sens. Chuck Schumer, Cory Booker and Ron Wyden. The trio introduced a draft version of the bill, The Cannabis Administration and Opportunity Act (CAOA), on Wednesday.

The Nasdaq welcomed its third psychedelics company this week, with the acquisition of MagicMed Industries by Enveric Biosciences ENVB -1.01% in an all-stock deal. “It’s a really exclusive group listed on the Nasdaq, and that access to capital is going to be a game-changer for everybody,” MagicMed’s CEO and president Dr. Joseph Tucker told Benzinga.

Dimensions Health Centres (“Dimensions”), a psychedelic treatment company, officially announced the company formation and subsequent closure of an initial, oversubscribed round of funding.  The management team is led by CEO and Co-Founder Christopher Dawson,  COO and co-founder Andrew Galloway, and Chairperson and Co-Founder David Eden.